SERPINE1 and obstructive sleep apnea syndrome: Given that PAI-1 is an independent risk factor for MACE, that PAI-1 shows elevated levels in OSA patients, and that there is a failure of conventional treatments to prevent adverse cardiovascular outcomes in OSA patients, it is tempting to propose that targeting PAI-1 may be advantageous in OSA patients with a risk of CVD.